The comparison between luminal A and HER2-enriched subtypes shown in Fig 1d, also revealed rather distinct entities, where the markers ESR1 and HER2 (alias ERBB2) are main differentiators between these two molecular breast cancer subtypes. This evidence concerns the gene ERBB2 and breast cancer.